# Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer

> **NCT00036868** · PHASE2 · COMPLETED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 90 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** trastuzumab
- **DRUG:** CMF regimen
- **DRUG:** cyclophosphamide
- **DRUG:** fluorouracil
- **DRUG:** methotrexate

## Key facts

- **NCT ID:** NCT00036868
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** 2009-06
- **Final completion:** 2010-02
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2024-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00036868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00036868, "Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00036868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*